- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GEMS sees healthy growth in 1999
GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is
GE Medical Systems garnered praise when GE announced its fiscal 1999 financial results. The Fairfield, CT, conglomerate said that acceptance of its Six Sigma-designed products caused its medical business to grow by 25% for the year. Six Sigma is GEs quality improvement program, which is being applied company-wide.
Many of GEs 1999 accomplishments culminated at last Decembers RSNA conference. There it completed its acquisition of OEC Medical Systems and introduced a new high-field open MRI system, GE Sigma OpenSpeed. Following the meeting, GE won a recommendation from a Food and Drug Administration panel for clearance of its digital mammography unit, Senographe 2000D (SCAN 1/12/00, 11/24/99, and 9/18/99).
For the year, GE reported revenues of $112 billion, up 11% compared with $100 billion in 1998. The company posted earnings of $10.7 billion, up 15% from 1998s $9.3 billion. GE did not break out sales and earnings figures for GE Medical Systems, other than to report on the businesss overall growth.
Can AI Enhance CT Detection of Incidental Extrapulmonary Abnormalities and Prediction of Mortality?
September 18th 2024Emphasizing multi-structure segmentation and feature extraction from chest CT scans, an emerging AI model demonstrated an approximately 70 percent AUC for predicting significant incidental extrapulmonary findings as well as two-year and 10-year all-cause mortality.
Comparing Digital Breast Tomosynthesis to Digital Mammography: What a Long-Term Study Reveals
September 17th 2024In a study involving over 272,000 breast cancer screening exams, digital breast tomosynthesis (DBT) had a higher breast cancer detection rate and a lower rate of advanced cancer presentation at the time of diagnosis in comparison to digital mammography.
